...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Prevalence of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital of Gujarat, India
【24h】

Prevalence of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital of Gujarat, India

机译:印度古吉拉特第三级护理医院Carbapenem耐药肠杆菌的患病率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Carbapenem Resistant Enterobacteriaceae (CRE) are major cause of community as well as healthcare associated infections and have limited treatment options.Measuring the magnitude of the problem of CRE, it is important for making strategies to lower its spread.Aim: To assess the incidence and prevalence rate of CRE in a tertiary care hospital of Gujarat, India.Materials and Methods: Retrospective data was collected for a period from 2014 to 2018 using Laboratory Information System (LIS).Prevalence of CRE was determined as number of CRE isolated per 100 Enterobacteriaceae isolated during the study period whereas incidence rate was determined as number of CRE cases per 1000 patient-days.Consumption of Carbapenems was calculated as Defined Daily Dose (DDD) per 1000 patient-days.Demographic data including age, gender, location in the hospital and sample type from which CRE was isolated was also analysed using Microsoft Excel.Results: The incidence of CRE cases per 1000 patient-days in 2014 to 2018 was 1.66, 2.11, 1.90, 2.26 and 1.91, respectively with an overall incidence of 1.99 per 1000 patient-days.The overall prevalence of CRE over a period of five years was found to be 29.07%.Klebsiella sp.was the most common CRE and had the highest percentage of Carbapenem resistance among all Enterobacteriaceae.Conclusion: The rate of CRE in present study was high and worrisome.Screening of the patient for CRE, source isolation and stringent implementation of infection control practices is required to confine the spread of CRE in this institute.
机译:Carbapenem抗肠杆菌(CRE)是社区的主要原因以及医疗保健相关的感染,并且有有限的治疗方案。释放CRE问题的程度,对于降低其展示率的策略是重要的:评估发病率和评估发病率古吉拉特邦,印度古吉拉特第三级护理医院的患病率。使用实验室信息系统(LIS)从2014年至2018年收集了回顾性数据。CRE的Prevalence被确定为每100个肠杆菌菌分离的CRE在研究期间分离,而入射率确定每1000例患者的CRE病例数。每1000例患者的日常剂量(DDD)计算Carbapenems的Carplation。包括年龄,性别,医院位置的定义数据。使用Microsoft Excel分析了分离CRE的样本类型。结果:2014年患者每1000例患者的CRE病例的发生率o 2018年为1.66,2.11,1.90,2.26和1.91,分别为每1000例患者的总体发病率1.99. CRE在五年内的总体流行率为29.07%.klebsiella sp.was最多常见的CRE和所有肠杆菌菌之间的鲤鱼疫苗含量最高。结论:本研究中CRE的速度高,令人担忧。患者对CRE,源隔离和严格实施感染控制实践需要限制传播克雷在本研究所。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号